All SynCardia sales and clinical staff have completed the required training in advance of the rollout. SynCardia will work directly with hospital and clinical teams to provide training materials, ...

Picard Medical, the company behind the SynCardia TAH, announced today that it plans to launch a new, FDA-cleared artificial ...

Presenter: Duffy Elmer, Engineering Project Manager, Picard Medical, Inc. The presentation will highlight benchtop performance data from the Emperor, SynCardia’s fully implantable next generation ...

Click to open image viewer. CC0 Usage Conditions ApplyClick for more information. The SynCardia temporary Total Artificial Heart (TAH-t) replaces the failing native heart and pumps blood through the ...

TUCSON, Ariz., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart ...

-Picard Medical / SynCardia Systems LLC mark historic milestone as a patient reaches 2,900 days of continuous support with the SynCardia Total Artificial Heart -- the longest timeframe in the world ...

Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world’s first total artificial heart approved by both the U.S. Food and ...

Picard Medical (PMI) announced that it would begin to incorporate an additional design component of an FDA-cleared accessory, CPC1 “Connector ...

Few total artificial hearts make it to human clinical trials, and only the SynCardia Total Artificial Heart has met the rigorous requirements for commercial approval. "Completely implantable heart ...

A private equity firm said it has completed its purchase of Tucson-based artificial heart maker SynCardia Systems in a bankruptcy sale and pledged to back the company’s growth. An affiliate of ...